Molecular Tumor Pathology
11 – 20 of 30
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
The roles of interleukin-1 receptor accessory protein in certain inflammatory conditions
(
- Contribution to journal › Scientific review
-
Mark
Synergistic Effects of Sanglifehrin-Based Cyclophilin Inhibitor NV651 with Cisplatin in Hepatocellular Carcinoma
(
- Contribution to journal › Article
-
Mark
Towards a treatment for mitochondrial disease : current compounds in clinical development
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Novel Cyclophilin Inhibitor Decreases Cell Proliferation and Tumor Growth in Models of Hepatocellular Carcinoma
(
- Contribution to journal › Article
- 2020
-
Mark
CYLD, a mechanosensitive deubiquitinase, regulates TGFβ signaling in load-induced bone formation
(
- Contribution to journal › Article
-
Mark
High expression of CD34 and α6-integrin contributes to the cancer-initiating cell behaviour in ultraviolet-induced mouse skin squamous cell carcinoma
(
- Contribution to journal › Article
-
Mark
Nemo-like kinase in development and diseases : Insights from mouse studies
(
- Contribution to journal › Scientific review
-
Mark
Discovery of epi-enprioline as a novel drug for the treatment of vincristine resistant neuroblastoma
(
- Contribution to journal › Article
-
Mark
Gene expression signature of acquired chemoresistance in neuroblastoma cells
(
- Contribution to journal › Article
-
Mark
Tumour suppressor 15-hydroxyprostaglandin dehydrogenase induces differentiation in colon cancer via GLI1 inhibition
(
- Contribution to journal › Article